Current stroke guidelines 1-3 recommend intravenous thrombolysis (IVT) using the recombinant tissue plasminogen activator (r-tPA) at a standard-dose (0.9mg/kg, alteplase) for patients with acute ischemic stroke (AIS). The gene discussed is PLAT; the disease is Stroke.